Influence of long‐term infusions on lidocaine kinetics

[1]  J. Lima,et al.  A comparison of methods of lidocaine administration in patients , 1981, Clinical pharmacology and therapeutics.

[2]  F. Karch,et al.  GLC assay for lidocaine in human plasma. , 1981, Journal of pharmaceutical sciences.

[3]  G. Wagner,et al.  Increased alpha-1-acid glycoprotein and lidocaine disposition in myocardial infarction. , 1980, Annals of internal medicine.

[4]  G. Tucker,et al.  Lignocaine and indocyanine green kinetics in patients following myocardial infarction. , 1980, British journal of clinical pharmacology.

[5]  D. Greenblatt,et al.  Reduction in lidocaine clearance during continuous infusion and by coadministration of propranolol. , 1980, The New England journal of medicine.

[6]  L. Benet,et al.  Noncompartmental determination of the steady-state volume of distribution. , 1979, Journal of pharmaceutical sciences.

[7]  D. S. Fredrick,et al.  Lidocaine infusions: effect of duration and method of discontinuation on recurrence of arrhythmias and pharmacokinetic variables. , 1979, American journal of hospital pharmacy.

[8]  C. Hignite,et al.  Quantitation of lidocaine and its deethylated metabolites in plasma and urine by gas chromatography-mass fragmentography. , 1978, Journal of chromatography.

[9]  J. LeLorier,et al.  Effect of the duration of infusion on the disposition of lidocaine in dogs. , 1977, The Journal of pharmacology and experimental therapeutics.

[10]  L. Prescott,et al.  Impaired Lignocaine metabolism in patients with myocardial infarction and cardiac failure. , 1976, British medical journal.

[11]  D C Harrison,et al.  Interrelationships of Hepatic Blood Flow, Cardiac Output, and Blood Levels of Lidocaine in Man , 1971, Circulation.

[12]  G. Wagner,et al.  Relationship between alpha 1-acid glycoprotein and lidocaine disposition in myocardial infarction. , 1981, Clinical pharmacology and therapeutics.